Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOK
2101
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.46M | ﹤0.01% |
87,568
-63,644
| -42% | -$5.31M |
|
2102
Theravance Biopharma
TBPH
$874M
| $8.45M | ﹤0.01% |
402,535
-145,135
| -27% | -$3.73M |
|
2103
MidCap Financial Investment
MFIC
$801M
| $8.44M | ﹤0.01% |
881,859
+51,902
| +6% | +$469K |
|
2104
Westlake Chemical Partners
WLKP
$750M
| $8.44M | ﹤0.01% |
445,530
-68,625
| -13% | -$1.25M |
|
2105
Acadia Pharmaceuticals
ACAD
$4.39B
| $8.43M | ﹤0.01% |
173,932
-7,512
| -4% | -$361K |
|
2106
Century Communities
CCS
$1.96B
| $8.42M | ﹤0.01% |
274,604
-87,460
| -24% | -$2.09M |
|
2107
Trex
TREX
$4.66B
| $8.4M | ﹤0.01% |
129,200
+5,892
| +5% | +$314K |
|
2108
VanEck Oil Services ETF
OIH
$1.89B
| $8.4M | ﹤0.01% |
68,938
-479,814
| -87% | -$53.7M |
|
|
DWFI
2109
DELISTED
SPDR Dorsey Wright Fixed Income Allocation ETF
DWFI
| $8.4M | ﹤0.01% |
361,069
-85,084
| -19% | -$1.93M |
|
2110
CVB Financial
CVBF
$4.03B
| $8.39M | ﹤0.01% |
447,612
+43,381
| +11% | +$828K |
|
|
PPBI
2111
DELISTED
Pacific Premier Bancorp
PPBI
| $8.39M | ﹤0.01% |
386,816
+163,793
| +73% | +$3.28M |
|
2112
ProShares Trust Short MSCI Emerging Markets
EUM
$11.1M
| $8.36M | ﹤0.01% |
242,480
+158,927
| +190% | +$5.96M |
|
2113
Group 1 Automotive
GPI
$3.48B
| $8.34M | ﹤0.01% |
126,331
-147,443
| -54% | -$8.44M |
|
|
HPS
2114
John Hancock Preferred Income Fund III
HPS
$458M
| $8.31M | ﹤0.01% |
529,771
+52,257
| +11% | +$789K |
|
2115
Sensata Technologies
ST
$6.81B
| $8.31M | ﹤0.01% |
223,143
-33,915
| -13% | -$1.2M |
|
2116
Cerence
CRNC
$403M
| $8.3M | ﹤0.01% |
203,278
+156,443
| +334% | +$4.49M |
|
2117
eHealth
EHTH
$43.8M
| $8.3M | ﹤0.01% |
84,492
-11,140
| -12% | -$1.3M |
|
|
JRO
2118
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $8.3M | ﹤0.01% |
1,057,474
-319,960
| -23% | -$2.46M |
|
2119
BellRing Brands
BRBR
$1.51B
| $8.3M | ﹤0.01% |
416,298
+311,289
| +296% | +$5.78M |
|
|
RP
2120
DELISTED
RealPage, Inc.
RP
| $8.3M | ﹤0.01% |
127,668
+70,915
| +125% | +$4.47M |
|
2121
WisdomTree Global High Dividend Fund
DEW
$155M
| $8.3M | ﹤0.01% |
215,985
-31,167
| -13% | -$1.16M |
|
2122
Terreno Realty
TRNO
$7.58B
| $8.28M | ﹤0.01% |
157,347
-6,279
| -4% | -$326K |
|
2123
PetMed Express
PETS
$42.3M
| $8.28M | ﹤0.01% |
232,334
-95,203
| -29% | -$3.31M |
|
2124
La-Z-Boy
LZB
$1.64B
| $8.28M | ﹤0.01% |
305,985
-27,728
| -8% | -$667K |
|
2125
ClearBridge Large Cap Growth Select ETF
LRGE
$374M
| $8.27M | ﹤0.01% |
202,588
-29,146
| -13% | -$1.1M |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.